Bench Press: BioWorld Looks at Translational Medicine
Monday, June 24, 2013
Several successful cancer drugs target receptor tyrosine kinases, which phosphorylate proteins to activate them. Now, a group from the Singaporean Agency for Science, Technology and Research has shown that a protein phosphatase may be a useful target for preventing metastasis in triple-negative breast cancer.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.